Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial.
Gopal NarangJonathan MooreKevin WymerYu-Hui ChangElisabeth LimOlufunmilola AdeleyeMitchell R HumphreysKaren L SternPublished in: The Journal of urology (2023)
This randomized, blinded, placebo-controlled trial showed that cannabidiol oil is safe but ineffective when compared to placebo in reducing post-ureteroscopic stent discomfort or opioid usage. Despite the availability of numerous analgesic agents, stent symptoms continue to be a dissatisfier for most patients, suggesting additional work needs to focus on novel interventions and pain control.
Keyphrases
- double blind
- placebo controlled
- chronic pain
- clinical trial
- pain management
- phase iii
- neuropathic pain
- study protocol
- phase ii
- end stage renal disease
- newly diagnosed
- ejection fraction
- fatty acid
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- spinal cord
- spinal cord injury
- patient reported outcomes
- depressive symptoms
- patient reported